Clem Kerry M 4
4 · Acorda Therapeutics, Inc. · Filed Apr 4, 2023
Insider Transaction Report
Form 4
Clem Kerry M
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-03-31+77,300→ 77,300 totalExercise: $0.59Exp: 2033-03-31→ Common Stock (77,300 underlying)
Footnotes (1)
- [F1]Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to the options vest in equal quarterly installments over two years beginning on January 1, 2023 with the first quarterly installment vesting on April 1, 2023.